Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

38.51
Delayed Data
As of Oct 20
 +0.22 / +0.57%
Today’s Change
29.39
Today|||52-Week Range
45.87
+0.94%
Year-to-Date
Diamond Hill's Top 3 New Investments for the 3rd Quarter
Oct 19 / GuruFocus News - Paid Partner Content
Mylan Gets Complete Response Letter For Biosimilar Neulasta
Oct 11 / Zacks.com - Paid Partner Content
Pricing Pressure, Competition Remain Headwinds for Pharma Stocks
Oct 18 / Zacks.com - Paid Partner Content
Forget Teva (TEVA), Buy These 5 Drug Stocks Instead
Oct 09 / Zacks.com - Paid Partner Content
Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall
Oct 17 / Zacks.com - Paid Partner Content
US FDA approves generic competitor of Teva blockbuster drug
Oct 04 / FT.com - Paid Partner Content
Voyager Therapeutics (VYGR) Jumps: Stock Rises 7.8%
Oct 13 / Zacks.com - Paid Partner Content
Allergan deal with Mohawk tribe casts patent shadow
Sep 27 / FT.com - Paid Partner Content

Today’s Trading

Previous close38.29
Today’s open38.43
Day’s range37.95 - 38.63
Volume3,998,501
Average volume (3 months)6,475,659
Market cap$20.7B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)-5.85%
Earnings growth (next 5 years)+3.21%
Revenue growth (last year)+17.44%
P/E ratio16.6
Price/Sales1.79
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.38-0.43%
PRGOPerrigo Company PLC-0.09-0.10%
JAZZJazz Pharmaceuticals...-0.95-0.66%
ALNYAlnylam Pharmaceutic...-0.93-0.80%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.20
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts